CoapTech Competitors and Similar CompaniesClear all
CoapTech's competitors and similar companies include Evergen, Alcresta, Eyenovia and XVIVO Perfusion.
 Evergen Evergen (formerly known as RTI Surgical) is a global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. |  Alcresta Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases. |  Eyenovia Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform. |  XVIVO Perfusion XVIVO Perfusion is a medical technology company that develops machines and perfusion solutions. | ||
Founding Date | Founding Date 2016 | Founding Date 1998 | Founding Date 2011 | Founding Date 2014 | Founding Date 1998 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Baltimore, US HQ | Locations Alachua, US HQ Metz, FR Neunkirchen Am Brand, DE Houten, NL Singapore, SG Greenville, US Marquette, US see more | Locations Newton, US HQ | Locations New York, US HQ | Locations Mölndal, SE HQ Shanghai, CN Novegro Tregarezzo, IT Groningen, NL Lund, SE Mölndal, SE Aurora, US see more |
Employees | Employees 2717% increase | Employees 8915% decrease | Employees 82 | Employees 22100% increase | Employees 19320% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 47.3 m | Valuation ($) 1.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $280.9m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) $813.5k (FY, 2025) | Revenue (est.) kr812.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $140.7m (FY, 2018) | Cost of goods N/A | Cost of goods $303.3k (FY, 2025) | Cost of goods kr208.5m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $140.1m (FY, 2018) | Gross profit N/A | Gross profit $510.2k (FY, 2025) | Gross profit kr605.4m (FY, 2025) |
Net income | Net income N/A | Net income ($1.3m) (FY, 2018) | Net income N/A | Net income ($45.3m) (FY, 2025) | Net income kr25.2m (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 1.2m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 60m (over 8 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 3.6m | Total funding raised N/A | Total funding raised $ 139.4m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Evergen
HQ
Alachua, US
Employees
891↓ 5% decrease
Evergen (formerly known as RTI Surgical) is a global surgical implant company providing surgeons with safe biologic, metal and synthetic implants.
View companyAlcresta
HQ
Newton, US
Employees
82
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.
View companyEyenovia
HQ
New York, US
Employees
22
Eyenovia is a late-stage biopharmaceutical company with three lead programs in glaucoma, mydriasis and dry eye with a transformative ophthalmic delivery platform.
View companyXVIVO Perfusion
HQ
Mölndal, SE
Employees
193↑ 20% increase
XVIVO Perfusion is a medical technology company that develops machines and perfusion solutions.
View company